Xenical (Orlistat 120 mg Rx) and Alli (Orlistat 60 mg OTC) Capsules: Pancreatic and Gastric Lipase Inhibitor That Blocks ~30% of Dietary Fat Absorption for Weight Loss

Information last reviewed: May 2026 — for educational purposes only.

Orlistat is the only anti-obesity medication available in both over-the-counter (Alli 60 mg) and prescription (Xenical 120 mg) forms in the United States. It works by a unique, entirely peripheral mechanism — inhibiting pancreatic and gastric lipase enzymes in the GI tract, preventing them from breaking down dietary triglycerides (fats) into absorbable free fatty acids and monoglycerides. Undigested fats pass through the intestine intact and are excreted in the stool, reducing the total caloric extraction from dietary fat by approximately 30% at the Rx dose. Because orlistat is minimally absorbed systemically (absorption <1%), it has no central nervous system effects, does not affect heart rate or blood pressure, and has no stimulant, sedative, or mood-altering properties — a key safety advantage over many earlier anti-obesity agents.

Clinical trial weight loss data: At 120 mg TID (Xenical), mean additional weight loss compared to placebo (both with calorie-restricted diet) is approximately 3–5% of body weight over 1–2 years. This is modest compared to GLP-1 agonists (semaglutide: ~15% weight loss) but clinically meaningful — for a 200 lb person, 3–5% represents 6–10 lbs of additional fat loss. Orlistat also reduces progression from prediabetes to type 2 diabetes (XENDOS trial), reduces low-density lipoprotein cholesterol, and improves blood pressure modestly.

What Is Orlistat?

Orlistat is a hydrogenated derivative of lipstatin (a natural lipase inhibitor from Streptomyces toxytricini). It covalently bonds to the serine active site of lipase enzymes in the GI lumen — irreversibly inactivating them for the duration of each meal. Without lipase activity, ingested dietary fat (triglycerides) cannot be hydrolysed and absorbed across the intestinal mucosa. The mechanism of action provides a built-in behavioural feedback loop: eating high-fat meals while taking orlistat results in more pronounced and unpleasant GI side effects — effectively reinforcing adherence to a low-fat diet as part of the weight management programme.

Prescription/OTC Status

Alli (orlistat 60 mg) is available OTC without prescription — the only weight loss medication currently approved for OTC sale in the US. For OTC use, it is indicated for adults 18+ with a starting BMI ≥25 (overweight) used together with a reduced-calorie, low-fat diet (approximately ≤15 g fat per meal). OTC Alli should not be used for more than 2 years without physician supervision. Xenical (orlistat 120 mg) is prescription-only — indicated for BMI ≥30 or BMI ≥27 with weight-related comorbidities (hypertension, diabetes, hyperlipidaemia).

Strengths and Available Forms

• Alli 60 mg capsules (OTC) — available without prescription; half the Rx dose; take one capsule with each main fat-containing meal, up to 3 capsules per day; take with the meal or within 1 hour after eating; skip dose if meal contains no fat or if a meal is skipped
• Xenical 120 mg capsules (Rx) — prescription-strength dose; take one 120 mg capsule three times daily with each main meal containing fat; same timing rules — with or within 1 hour of meal; skip if meal has no fat

Fat-soluble vitamin supplementation: Orlistat reduces absorption of fat-soluble vitamins (A, D, E, K) because undigested fat is also a carrier for these vitamins. A daily multivitamin containing fat-soluble vitamins should be taken — at bedtime or at least 2 hours before or after orlistat doses to maximise vitamin absorption.

Price of Xenical and Alli Orlistat

Alli 60 mg OTC: approximately $1–2 per day for 3 capsules, available at pharmacies and online retailers. Generic OTC orlistat 60 mg is also available at lower cost. Xenical 120 mg Rx: significantly more expensive, but generic Rx orlistat 120 mg is widely available and substantially cheaper than brand Xenical. Insurance coverage for prescription orlistat varies widely — often requires prior authorisation as anti-obesity medications.

Frequently Asked Questions

What are the GI side effects of orlistat and how can they be reduced?

Gastrointestinal side effects are the primary complaint with orlistat — they are directly caused by unabsorbed fat passing through the colon: oily/fatty stools (steatorrhoea), oily spotting of undergarments, faecal urgency (needing the toilet suddenly), increased frequency of bowel movements, and flatus with discharge. These effects are more severe when high-fat meals are consumed. The practical message: symptoms are minimised by maintaining fat intake at approximately 30% of calories (≤15 g fat per meal). Eating low-fat meals makes orlistat well-tolerated; high-fat cheat meals on orlistat result in immediate, distressing GI consequences — which partly explains why clinical trial dropout rates are significant, and why some patients find the GI side effects a deterrent to high-fat choices (a potentially useful behavioural effect).

Does orlistat interact with other medications?

Orlistat has a small number of clinically important drug interactions related to its fat absorption inhibition effect. Warfarin: orlistat may reduce absorption of vitamin K from food, potentially increasing INR — monitor INR more carefully in patients starting or stopping orlistat. Cyclosporine: orlistat significantly reduces cyclosporine absorption — take cyclosporine at least 3 hours before or after orlistat; serum cyclosporine levels should be monitored more frequently. Levothyroxine: orlistat may reduce levothyroxine absorption — separate administration by ≥4 hours and monitor TSH. Antiepileptic drugs: reduced absorption of valproate, lamotrigine — increased seizure risk reported; use with caution and monitor seizure frequency. Amiodarone: clinical monitoring advised. Fat-soluble vitamins are absorbed with dietary fat — supplementation required.

Can orlistat be used long-term and is it safe for the kidneys?

Orlistat is approved for long-term use (up to 4 years in clinical trials) and has a good long-term safety profile given its minimal systemic absorption. However, a rare but serious concern is oxalate nephropathy — when orlistat prevents fat absorption, unabsorbed fatty acids bind calcium in the gut, leaving less calcium available to bind dietary oxalate. Unbound oxalate is then absorbed in larger quantities and excreted in the urine, potentially causing calcium oxalate kidney stones or, in severe cases, oxalate crystaluria and kidney injury. This risk is most clinically relevant in patients with pre-existing kidney disease, inflammatory bowel disease, or prior kidney stones. Such patients should have renal function monitored and may need to limit high-oxalate foods (spinach, nuts, chocolate, coffee) while using orlistat. For patients with normal renal function and no risk factors, the kidneys are not meaningfully affected by orlistat.

← Back to Weight Loss Medications